Literature DB >> 18662514

Inflammatory muscle disease assessment.

Tim Y-T Lu1, Kristine P Ng, David A Isenberg.   

Abstract

In recent years, idiopathic inflammatory muscle disease assessment has advanced significantly with the development of an international consensus on outcome measurement indices. The International Myositis Assessment and Clinical Studies Group continues to evaluate the validity and reliability of various disease activity and disease damage tools, which will facilitate adequately controlled randomized trials of recently developed therapeutic agents.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18662514     DOI： 10.1007/s11926-008-0052-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  23 in total

1.  Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings.

Authors:  H D Tazelaar; R W Viggiano; J Pickersgill; T V Colby
Journal:  Am Rev Respir Dis       Date:  1990-03

2.  Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.

Authors:  A Bohan; J B Peter; R L Bowman; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

3.  Validity of a vasculitis activity index for systemic necrotizing vasculitis.

Authors:  Q E Whiting-O'Keefe; J H Stone; D B Hellmann
Journal:  Arthritis Rheum       Date:  1999-11

Review 4.  Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.

Authors:  F W Miller; L G Rider; Y L Chung; R Cooper; K Danko; V Farewell; I Lundberg; C Morrison; L Oakley; I Oakley; C Pilkington; J Vencovsky; K Vincent; D L Scott; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-11       Impact factor: 7.580

5.  Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.

Authors:  Kerry B Stone; Chester V Oddis; Noreen Fertig; Yasuhiro Katsumata; Mary Lucas; Molly Vogt; Robyn Domsic; Dana P Ascherman
Journal:  Arthritis Rheum       Date:  2007-09

Review 6.  Clinical assessment in adult onset idiopathic inflammatory myopathy.

Authors:  S M Sultan
Journal:  Curr Opin Rheumatol       Date:  2004-11       Impact factor: 5.006

Review 7.  Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis.

Authors:  T J Bohlmeyer; A H Wu; M B Perryman
Journal:  Rheum Dis Clin North Am       Date:  1994-11       Impact factor: 2.670

8.  Reliability and validity of the myositis disease activity assessment tool.

Authors:  Shabina M Sultan; Elizabeth Allen; Chester V Oddis; Patrick Kiely; Robert G Cooper; Ingrid E Lundberg; Jiri Vencovsky; David A Isenberg
Journal:  Arthritis Rheum       Date:  2008-11

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.

Authors:  Stéphanie Christen-Zaech; Roopa Seshadri; Joyce Sundberg; Amy S Paller; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.